In the University Medical Center Utrecht, research is concentrated in six programs (cardiovascular health, personalized cancer care, child health, infection & immunity, regenerative medicine and brain) with each a limited number of disease targets. Patient care is integrated in these programs. A multidisciplinary approach guarantees patients benefit from the latest available expertise and innovative technological solutions. Interaction with patients and society creates an ‘innovation loop’ where societal issues guide scientific research and where scientific results quickly move from bench to bedside. Societal stakeholders are involved in all research phases, from prioritizing research questions to evaluating impact. In total ~12000 people work within the UMC Utrecht with ~1000 researchers.

The Nanomedicine laboratory @ University Medical Center Utrecht is interested in biological and synthetic nanoparticles for diagnosis and therapy. Key areas of expertise are extracellular vesicles, non-coding RNA and synthetic drug delivery systems (such as liposomes and polymers). Our work spans the entire nanomedicine field from characterization of nanoparticles via in vitro study of their behaviour to pre-clinical evaluation and measurements on clinical samples. To support these broad activities, we collaborate with fundamental scientists, technological researchers, clinical chemists and medical doctors as well as with industry.

We are an international multidisciplinary team with a diverse background in biomedical sciences. We are active in national, European and intercontinental collaborations and have successfully obtained personal grants and project grants.